MTHFR C677T: What It Means and What to Do

The MTHFR C677T variant (rs1801133) is one of the most commonly discussed genetic variants in health and wellness. It affects the MTHFR gene, which encodes an enzyme critical to folate metabolism and methylation — processes your body uses every day to support cell division, DNA repair, neurotransmitter production, and homocysteine regulation.

This article explains what MTHFR C677T actually does, what the research says about its health implications, and practical steps you can take — starting with diet, not supplements. For a broader look at how methylation is measured — including blood work and genetic panels — see our methylation testing guide.

What the MTHFR C677T Variant Is

MTHFR stands for methylenetetrahydrofolate reductase. It is an enzyme that converts dietary folate (vitamin B9) into its active form, 5-methyltetrahydrofolate (5-MTHF), which your body uses for methylation reactions.

The C677T variant is a single nucleotide change in the MTHFR gene — a C (cytosine) is replaced by a T (thymine) at position 677. This changes an amino acid in the enzyme, making it less stable and less active, particularly at higher body temperatures.

This is a common variant. Roughly 10–15% of people of European ancestry are homozygous (TT), and about 40–50% are heterozygous (CT). Frequencies vary by population — the TT genotype is more common in Hispanic and Southern European populations and less common in African populations.

How C677T Affects Folate Metabolism

The impact of C677T on MTHFR enzyme activity depends on whether you carry one copy (heterozygous, CT) or two copies (homozygous, TT) of the variant:

• CC (no variant copies): Normal MTHFR enzyme activity. Standard folate metabolism.
• CT (one variant copy — heterozygous): Approximately 35% reduced enzyme activity. For most people, this has minimal clinical impact if dietary folate intake is adequate.
• TT (two variant copies — homozygous): Approximately 70% reduced enzyme activity. This is the genotype most associated with elevated homocysteine levels, particularly when folate intake is low.

Reduced MTHFR activity means your body converts less dietary folate into its active form (5-MTHF). This can lead to higher homocysteine levels — an amino acid that, at elevated levels, is associated with cardiovascular risk in population studies. However, having the TT genotype does not mean you will have elevated homocysteine. Adequate folate intake can compensate for reduced enzyme activity in many cases.

What the Research Says

MTHFR C677T is one of the most studied genetic variants in nutritional genomics. The research literature is extensive but requires careful interpretation:

• Homocysteine: The association between TT genotype and elevated homocysteine is well-established and replicated across many studies. This is the most consistent finding.
• Cardiovascular risk: Some meta-analyses show a modest association between TT genotype and cardiovascular risk, but this appears to be largely mediated by homocysteine levels and folate status — meaning adequate folate may mitigate the association.
• Neural tube defects: Maternal TT genotype is associated with increased risk of neural tube defects, which is one reason adequate folate before and during pregnancy is universally recommended regardless of genotype.
• Other associations: Various studies have linked MTHFR C677T to conditions ranging from depression to migraine to certain cancers. Most of these associations are modest, not always replicated, and influenced heavily by folate status and other environmental factors.

The key takeaway: having the MTHFR C677T variant — even homozygous TT — is not a disease. It is a common genetic variation that affects one metabolic pathway. Its health impact depends heavily on your folate intake and overall nutritional status.

Food-First Folate Strategies

For most people with MTHFR C677T variants, the most practical step is ensuring adequate folate intake through diet. Natural food folate is already in a form that does not require the MTHFR enzyme step that the variant affects — making it a particularly efficient strategy.

High-folate foods:

• Dark leafy greens (spinach, kale, collard greens, romaine lettuce)
• Legumes (lentils, chickpeas, black beans, edamame)
• Asparagus, Brussels sprouts, broccoli
• Avocado
• Citrus fruits and juices
• Fortified grains (bread, cereal, pasta) — note these contain folic acid, not natural folate

A diet rich in these foods can provide adequate folate for most people, including those with the CT genotype. For the TT genotype, dietary folate is still the recommended starting point, though some individuals may benefit from additional support — which is where the methylfolate vs. folic acid conversation becomes relevant.

Methylfolate vs. Folic Acid: Context That Matters

Folic acid is the synthetic form of folate found in supplements and fortified foods. Your body must convert it through several enzymatic steps — including the MTHFR-dependent step — to reach the active form (5-MTHF).

Methylfolate (also called 5-MTHF or L-methylfolate) is the already-active form that bypasses the MTHFR enzyme entirely. For people with significantly reduced MTHFR activity (particularly TT homozygotes), methylfolate supplements may theoretically be more bioavailable than folic acid.

However, this is an area where the science is less settled than supplement marketing suggests. Folic acid fortification has been enormously successful at reducing neural tube defects across populations — including in people with MTHFR variants. The clinical evidence that switching from folic acid to methylfolate produces meaningfully better health outcomes for MTHFR C677T carriers is limited.

If you are considering methylfolate supplementation, discuss it with your healthcare provider. They can assess your homocysteine levels, overall folate status, and clinical context to determine whether it would be beneficial for your specific situation.

When to Talk to Your Doctor

Most people with MTHFR C677T variants do not need medical intervention. However, consider discussing your results with a healthcare provider if:

• You have the homozygous TT genotype and want to check your homocysteine levels
• You are pregnant, planning pregnancy, or have a history of pregnancy complications
• You have a personal or family history of cardiovascular disease
• You have unexplained elevated homocysteine on lab work
• You are taking medications that interact with folate metabolism (such as methotrexate)

Your doctor can order a homocysteine blood test to see whether your MTHFR variant is actually affecting your levels in practice. Genetic predisposition does not always translate to a measurable clinical effect — that is what lab work determines.

What Your DNA Data Can Show

If you have raw data from 23andMe, AncestryDNA, or similar services, your MTHFR C677T genotype (rs1801133) is almost certainly included. Consumer genotyping arrays reliably cover this variant, as well as the A1298C variant (rs1801131) — another MTHFR variant with a milder effect on enzyme activity.

DecodeMyBio's Nutrition & Methylation Report analyzes both MTHFR variants alongside COMT, FUT2, VDR, BCMO1, TCN2, and other nutrient-metabolism genes from your existing DNA data. The report provides your genotype, a plain-language explanation of what it means, evidence ratings, and practical context — including the food-first strategies described above.

To learn more about what nutrigenomics can and cannot tell you, see our introductory guide. For details on the MTHFR gene itself — including the A1298C variant and how the two interact — see the MTHFR gene page.

Frequently Asked Questions

What does it mean if I have the MTHFR C677T variant?

It means you carry a common genetic change that reduces the activity of the MTHFR enzyme, which processes folate. One copy (CT) reduces activity by about 35%. Two copies (TT) reduce it by about 70%. This is not a disease — it is a normal variation that may affect folate metabolism, especially when dietary folate intake is low.

Should I take methylfolate if I have MTHFR C677T?

Not necessarily. A food-first approach to folate is recommended for most people. Methylfolate supplementation may be worth discussing with your healthcare provider if you have the TT genotype and lab work shows elevated homocysteine or low folate. Do not start supplements based solely on genetic results.

Is MTHFR C677T dangerous?

No. It is a common variant found in 40–60% of many populations (heterozygous CT) and 10–15% (homozygous TT). It is associated with reduced enzyme activity, not a disease. Health impact depends largely on dietary folate intake and overall nutritional status.

Does 23andMe test for MTHFR C677T?

Yes. The rs1801133 variant (MTHFR C677T) is included in 23andMe and AncestryDNA genotyping arrays. Your raw data contains this variant, though 23andMe's consumer reports may not highlight it prominently. A dedicated analysis can extract and interpret it in a nutritional context.

Should I get my homocysteine levels tested?

If you have the homozygous TT genotype, it may be worth asking your doctor about a homocysteine blood test. This shows whether the variant is actually affecting your levels in practice. Genetics indicates predisposition; blood work shows current status. Many people with TT genotype have normal homocysteine when folate intake is adequate.